STOCK TITAN
  1. Home
  2. Sec-filings
  3. ENVA
  4. [Form 4] Enova International, Inc. Insider Trading Activity

Enova (ENVA) grants CSO 3,038 non-qualified options with SAR feature

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Enova International’s Chief Strategy Officer Kirk Chartier received a grant of 3,038 non-qualified stock options with a tandem stock appreciation right (SAR). The options carry an exercise price of $166.88 per share and expire on May 13, 2033.

The options vest in roughly equal one-third installments on May 13, 2027, May 13, 2028 and May 13, 2029, contingent on continued employment. The SAR can be exercised only if a Change in Control occurs and a qualifying Offer is made, allowing a cash amount based on the excess of the Offer Value Per Share over the exercise price.

Positive

  • None.

Negative

  • None.

Insights

Routine equity grant giving Enova’s CSO long-term, change-in-control-linked incentives.

Kirk Chartier, Enova’s Chief Strategy Officer, received 3,038 non-qualified stock options with a $166.88 exercise price, expiring on May 13, 2033. This is a compensation-related award (code A), not an open-market purchase or sale.

The options vest in three equal tranches on May 13, 2027, May 13, 2028 and May 13, 2029, aligning incentives with multi-year service. A tandem stock appreciation right pays value only upon a qualifying Change in Control and Offer, tying additional upside to potential corporate control events.

The filing shows 3,038 derivative securities following this transaction, with no remaining derivative positions listed elsewhere in this document. As a standard executive option grant without cash trading, this is generally viewed as routine compensation rather than a directional signal about Enova’s share price.

Insider Chartier Kirk
Role Chief Strategy Officer
Type Security Shares Price Value
Grant/Award Non-Qualified Stock Option (right to buy) with limited SAR 3,038 $0.00 --
Holdings After Transaction: Non-Qualified Stock Option (right to buy) with limited SAR — 3,038 shares (Direct, null)
Footnotes (1)
  1. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: May 13, 2027, May 13, 2028 and May 13, 2029.
Options granted 3,038 options Non-qualified stock options with SAR granted to CSO
Exercise price $166.88 per share Strike price of granted options
Expiration date May 13, 2033 Option and SAR expiration
Vesting date 1 May 13, 2027 First one-third of options vest
Vesting date 2 May 13, 2028 Second one-third of options vest
Vesting date 3 May 13, 2029 Final one-third of options vest
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy) with limited SAR"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
stock appreciation right financial
"The limited stock appreciation right ("SAR") and employee stock option were granted in tandem."
A stock appreciation right (SAR) is a form of employee pay that gives the holder the right to receive the increase in a company's share price over a set reference price, paid in cash or shares, without having to buy stock first. It matters to investors because SARs can create future cash outflows or dilute existing shareholders if settled in stock, and they align employee incentives with share-price performance like a bonus tied to a home's price rise.
Change in Control financial
"only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
Offer Value Per Share financial
"The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days"
tender offer financial
""Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power"
A tender offer is a proposal made by a person or company to buy shares from existing shareholders at a set price, usually higher than the current market value, within a specific time frame. It matters to investors because it can lead to a change in ownership or control of a company, and shareholders must decide whether to sell their shares at the offered price.
exchange offer financial
""Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power"
An exchange offer is a proposal where a company asks investors to swap existing securities, like bonds or shares, for new ones, often with different terms or maturity dates. It matters to investors because it can affect the value of their holdings and the company's financial strategy, potentially providing benefits like better interest rates or reduced debt.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chartier Kirk
(Last)(First)(Middle)
C/O ENOVA INTERNATIONAL, INC.
175 W. JACKSON BOULEVARD, SUITE 600
(Street)
CHICAGO ILLINOIS 60604
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Enova International, Inc. [ ENVA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Strategy Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (right to buy) with limited SAR(1)(2)$166.8805/13/2026A3,038 (3)05/13/2033Common stock; par value $0.00001 per share3,038$03,038D
Explanation of Responses:
1. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
2. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
3. The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: May 13, 2027, May 13, 2028 and May 13, 2029.
/s/ Sean Rahilly, as attorney in fact05/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Enova (ENVA) Chief Strategy Officer Kirk Chartier receive in this Form 4?

Kirk Chartier received a grant of 3,038 non-qualified stock options with a tandem stock appreciation right. The options allow him to buy Enova common stock at $166.88 per share as part of his executive compensation package, subject to vesting conditions over several years.

What are the key terms of Kirk Chartier’s Enova (ENVA) stock options?

The grant covers 3,038 stock options with a $166.88 exercise price, expiring May 13, 2033. The options vest in substantially equal one-third increments on May 13, 2027, May 13, 2028, and May 13, 2029, assuming Chartier remains employed through each vesting date.

How does the stock appreciation right (SAR) in the Enova (ENVA) grant work?

The limited SAR is paired with the option, so exercising one cancels the other. The SAR can be exercised only after a Change in Control and during a 30-day window, paying the excess of Offer Value Per Share over $166.88 times the shares exercised, but only if a qualifying Offer occurs.

Is Kirk Chartier’s Enova (ENVA) Form 4 transaction a market buy or sell?

No, this Form 4 reports a compensation-related award, not an open-market trade. The transaction code A indicates a grant or award acquisition of derivative securities, meaning Chartier received 3,038 stock options and an associated SAR rather than buying or selling shares in the market.

When can the Enova (ENVA) stock appreciation right be exercised by Kirk Chartier?

The SAR may be exercised only from the first day after a Change in Control of Enova until the thirtieth day following that date. It becomes payable only if a qualifying tender or asset Offer is made that meets specified ownership or asset fair market value thresholds.